CytomX Therapeutics CTMX
NASDAQ CTMX
$2.63 -0.09 (-3.31%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Return on Assets [ROA] (2015 - 2026)

Updated

CytomX Therapeutics (CTMX) recorded Return on Assets [ROA] of -21.51% in Q2 2026, down 56.59 percentage points from 35.08% a year earlier but up 1.64 percentage points from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) Return on Assets [ROA] (2015 - 2026) Analysis & Trends

For FY2025, CytomX Therapeutics reported Return on Assets [ROA] of -12.77%, down 32.54 percentage points from FY2024.

  • Annual Return on Assets [ROA] has a five-year change of +5.76 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at 19.77% in FY2024 (+20.02 pp), -0.25% in FY2023 (+32.84 pp), -33.09% in FY2022 (+0.11 pp) and -33.20% in FY2021 (-14.68 pp).
  • Quarterly Return on Assets [ROA] has ranged from -51.53% in Q3 2022 to 37.99% in Q1 2025 over the past five years.
  • On a year-over-year basis, Return on Assets [ROA] has declined for three consecutive quarters, with an average year-over-year change of -6.13 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 46.80 percentage points in Q3 2023, against a drop of 61.14 percentage points in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -23.15% (Q1 2026), -11.21% (Q4 2025) and 16.81% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 CytomX Therapeutics 592.69 Mn -364.98 Mn - -21.51%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.51%
Mar 31, 2026 -23.15%
Dec 31, 2025 -11.21%
Sep 30, 2025 16.81%
Jun 30, 2025 35.08%
Mar 31, 2025 37.99%
Dec 31, 2024 24.56%
Sep 30, 2024 9.28%
Jun 30, 2024 6.45%
Mar 31, 2024 8.56%
Dec 31, 2023 -0.27%
Sep 30, 2023 -4.73%
Jun 30, 2023 -19.03%
Mar 31, 2023 -28.51%
Dec 31, 2022 -40.75%
Sep 30, 2022 -51.53%
Jun 30, 2022 -45.71%
Mar 31, 2022 -39.14%
Dec 31, 2021 -32.61%
Sep 30, 2021 -27.15%
API Access

CytomX Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CTMX&period=max&api_key=YOUR_API_KEY